Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4799668
Max Phase: Preclinical
Molecular Formula: C13H11F3N2O3S
Molecular Weight: 332.30
Molecule Type: Unknown
Associated Items:
ID: ALA4799668
Max Phase: Preclinical
Molecular Formula: C13H11F3N2O3S
Molecular Weight: 332.30
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Nc1ccc(NS(=O)(=O)c2ccc(O)cc2)cc1C(F)(F)F
Standard InChI: InChI=1S/C13H11F3N2O3S/c14-13(15,16)11-7-8(1-6-12(11)17)18-22(20,21)10-4-2-9(19)3-5-10/h1-7,18-19H,17H2
Standard InChI Key: DZTLAGGCPZDEOE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 332.30 | Molecular Weight (Monoisotopic): 332.0442 | AlogP: 2.79 | #Rotatable Bonds: 3 |
Polar Surface Area: 92.42 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.08 | CX Basic pKa: 2.31 | CX LogP: 2.21 | CX LogD: 2.13 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.75 | Np Likeness Score: -1.28 |
1. Xu F,Zhao Y,Zhou H,Li C,Zhang X,Hou T,Qu L,Wei L,Wang J,Liu Y,Liang X. (2020) Synthesis and evaluation of 3-(4-(phenoxymethyl)phenyl)propanoic acid and N-phenylbenzenesulfonamide derivatives as FFA4 agonists., 30 (24): [PMID:33127539] [10.1016/j.bmcl.2020.127650] |
Source(1):